What You Need To Know About Canine Lymphoma

THE BREGMAN VETERINARY GROUP 

www.BregmanVetGroup.com

Dogs’ immune systems are often put at risks when they begin chemotherapy for canine lymphoma cancer. Recent studies at Texas A&M University and University ofTexas MD Anderson Cancer Center have since found that the t- cells taken from a dog before chemotherapy is begun can be cultured to produce more of the important t-cells and be implanted back into the blood stream once the chemotherapy is completed, which can help fight the B-cell lymphoma.

One of the Veterinary Oncologists at Texas A&M, Dr. Heather Wilson, explains how her results were better than expected and looking forward to moving along with the study. The next phase would include, genetically altering the t-cells to make them more specific, allowing for long term remission. It is thought that it has very minimal side-affects and seems to be a perfect option for humans who can’t tolerate chemotherapy’s harsh side effects, especially for young children.

One of the main problems with canine lymphoma cancer is that dogs given standard chemotherapy often only experience one year of durable remission, along with the side-affects.

Did you find this information helpful? Check out more helpful ways to protect and care for you furry friends on our Facebook page!